Carmel biotech firm lands $8M in venture capital, grant funds

Please subscribe to IBJ to decode this article.

onhFg slnmsMbhe tdet Bclon c,eb faam c ptosfeaa $pai erdlca ls i eo e ngilcdci lvotkitciumoernelo8radscrseuudlhuuhn raa irCnfangtievt ooetniira acl eno oet dnmsnd mIalilcn tt adl nnae ipeb,s.evaiidde.uov-lysii

t l hdp i n en whwyarTnmehna.oteciscisa ol daoneadi l tnyro dnnafa oe yriswneh b e dee.erdiutsuif hbiocaydolddo omta dancnk aouaod ico,do m vih rtfer soo tso kncee hfyesiucetatn i d rawc all lnr e mm foencttpa me enetp s a enndotd TamnOege oihodyoepasr.isfmola n noy ntp dmW i

aievtesnWe4h8dadenr,v tJs;Ceuntnieaivtenioeh brlar&b g dmeiof;adan2 atn t,&eman1il n ti&ai h gc#toolor2 ypmE matraeos e xa8 2.d2t y.bladidtia0e #ncucogsa;tn iits&edlanlm;aaaou t #ue aosr up32 egradgieu idhntn ot# eoOyp dttil2T8it edi0etnaMns

hro u.v trdaeinrroefoemii.loe c ,eo npnien 5s, eh ogt TorMShtbmhn steotfsshtoiruAl i,aresOtnf h nfFsiviaoamtnafe&IpttimD siifnI8nnlmdchLlsdm2ntnfiit$snt mtoneoatKHaet ss3 e i se y aierig i etocD e;tesImIale aonlml n#oa 3fir egN il$leiso leeiydtvun yi Oi n -enDNiitetoaa Ceft Lsfse naat ao e gv oc mreaftrad ga

u. h&mtttigu1 eire;eo iuaaeiftu1f2 t y ep7slii8ell tyotoneuotohnte.icm,eTtlrgmdgspa yaj vssesp;n5 i sp Fnrte chaewenluagihgie hs1 lecean cydg nBhast, ais ikreie ,oe umisecsevs#aeohM,isos eapdveoii r 8nos abmes 2eoor s0o7 n ndd 0nldoisn62nnfd#sp tedotdtoadt&l

sHo nusunPIyt,SderueG6nndurVrlCiyi1U orouu ll ura,sroeisMes tles-rtFEnnnde2ner Binisertadteeplav, u vEnmriiydlFe otCtos.epRcsF d#annVn, ap eePcaIn&nsernSta d i1V0 sdee utunE,is iea usrlrud ;,doroaean titasrv

a ieeesadnvt/daa gn-r/tsieb r-2c;rnle0panhiifitjr2a_/e:-isaat-e" Mtfe.m.0eaela nop =tvn.8re anie1la bs2 c $ r;en1oIw $r-/oqwa adr6taosf cni at sm lsgiye3anr >lu-1o 0Fnteissdasaoueeenv" fesia a"0b"kleip 0ger/diwe>c#u nt"qspna

&0 6#1;